文献速递系统性红斑狼疮

P-糖蛋白在CD69+CD4+细胞中对增殖性狼疮肾炎发病及免疫抑制治疗无反应的作用

Role of P-glycoprotein on CD69+CD4+ cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy.
PubMed 文献 · RMD Open · 2017-07-14

研究纳入116例系统性红斑狼疮患者和10名健康成人,用流式细胞术检测外周血P-糖蛋白阳性CD4+细胞比例,并用免疫组化检查肾活检标本的P-糖蛋白表达。结果显示P-糖蛋白+CD69+CD4+细胞比例与系统性红斑狼疮疾病活动指数相关,且在糖皮质激素反应不佳者中更高,在增殖性狼疮肾炎对糖皮质激素反应不佳者中显著更高。作者认为活化CD4+ T细胞上的P-糖蛋白表达可能是治疗无反应的潜在标志物和新治疗靶点。

要点

  • 系统性红斑狼疮患者外周血P-糖蛋白阳性CD4+细胞和CD69阳性CD4+细胞比例均高于对照。
  • P-糖蛋白+CD69+CD4+细胞比例与系统性红斑狼疮疾病活动指数相关,且在糖皮质激素反应不佳者中更高。
  • 增殖性狼疮肾炎对糖皮质激素反应不佳者P-糖蛋白+CD69+CD4+细胞比例显著更高,肾间质可见P-糖蛋白阳性CD4+细胞明显聚集。

核心结论

  • 增殖性狼疮肾炎对糖皮质激素治疗无反应的患者外周血P-糖蛋白+CD69+CD4+细胞比例高,且这些细胞在肾组织聚集,提示活化CD4+ T细胞上的P-糖蛋白表达可能是治疗无反应的潜在标志物和新治疗靶点。

研究设计与样本

  • 研究用流式细胞术检测116例系统性红斑狼疮患者和10名健康成人外周血P-糖蛋白阳性CD4+细胞比例,并用免疫组化检查肾活检标本的P-糖蛋白表达。

主要发现

  • 系统性红斑狼疮患者外周血P-糖蛋白阳性CD4+细胞和CD69阳性CD4+细胞比例均高于对照。
  • P-糖蛋白+CD69+CD4+细胞比例与系统性红斑狼疮疾病活动指数相关,且在糖皮质激素反应不佳者中更高。
  • 增殖性狼疮肾炎对糖皮质激素反应不佳者P-糖蛋白+CD69+CD4+细胞比例显著更高。
  • 免疫抑制治疗的疗效取决于P-糖蛋白+CD69+CD4+细胞比例的调节。
  • 增殖性狼疮肾炎患者肾间质可见P-糖蛋白阳性CD4+细胞明显聚集,外周血P-糖蛋白+CD69+CD4+细胞比例高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: P-glycoprotein (P-gp) expression on activated lymphocytes in systemic lupus erythematosus (SLE) plays a role in active efflux of intracellular drugs, resulting in drug resistance. The role of P-gp-expressing lymphocytes in the pathogenesis of SLE remains unclear. The aim of this study was to determine the importance of P-gp+CD4+ cells in organ manifestations in refractory SLE. METHODS: The proportion of P-gp+CD4+ cells was determined by flow cytometry in peripheral blood of patients with SLE (n=116) and healthy adults (n=10). Renal biopsy specimens were examined by immunohistochemistry for P-gp expression. RESULTS: CD69 is a marker of CD4 cell activation. The proportion of both P-gp-expressing CD4+ cells and CD69-expressing CD4+ cells in peripheral blood was higher in SLE than control. The proportion of P-gp+CD69+CD4+ cells correlated with Systemic Lupus Erythematosus Disease Activity Index and was higher in poor responders to corticosteroids. Furthermore, the proportion of P-gp+CD69+CD4+ cells was significantly higher in proliferative lupus nephritis (LN) with poor response to corticosteroids. The efficacy of immunosuppressive therapy depended on the regulation of the proportion of P-gp+CD69+CD4+ cells. Marked accumulation of P-gp+CD4+ cells in renal interstitial tissue and high proportion of peripheral P-gp+CD69+CD4+ cells were noted in patients with proliferative LN. CONCLUSIONS: The results showed high proportion of P-gp+CD69+CD4+ cells in peripheral blood and their accumulation in renal tissue in patients with proliferative LN refractory to CS therapy, suggesting that P-gp expression on activated CD4+ T cells is a potentially useful marker for refractoriness to treatment and a novel target for treatment.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tsujimura S, Adachi T, Saito K, et al. Role of P-glycoprotein on CD69+CD4+ cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy. RMD Open. 2017. PMID: 29225917. doi:10.1136/rmdopen-2016-000423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。